Zhengzhou university People's Hospital
Zhengzhou, Henan, 450000, China
NCT Number: NCT02641262
ST-segment elevation myocardial infarction (STEMI) remains among the most acute and critical diseases, with primary percutaneous coronary intervention (pPCI) and thrombolysis as mainstay reperfusion treatments. Real-world implementation of current guidelines for STEMI management has been assessed in developed countries and large Chinese cities. However, until now, there has been no registry on patients with STEMI in Henan, the most populated (about 100 million) and predominantly rural (66%) province in central China.
This registry is aimed to assess management practices, time delays, outcomes and reasons for not receiving reperfusion therapy in consecutive STEMI patients in reperfusion-capable hospitals, i.e., tertiary and secondary, in Henan province.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Zhengzhou, Henan, 450000, China
1)Diagnosis of STEMI is according to the third universal definition of myocardial infarction.
2)Before registry, a training program on study objectives, data collection, and STEMI management is given to the primary investigator and related staff at each participating center.
3)Henan institute of cardiovascular epidemiology will regularly monitored at least 10% of questionnaires for accuracy against medical records. If the questionnaires are not completed with 98% accuracy, all questionnaires are considered unqualified and this staff will be retrained.
4)Real-time automatic logic and range check on the completeness and validity of the data are integrated in the data entry system to control basic data quality. Henan ICE regularly provides data quality checks and sends queries for illogical, invalid or missing data elements to participating hospitals to review and revise. Participating centres who has the high error rate of data, and no change in 6 months shall be deemed abandoned automatically; participating centres who has the high quality of data will be issued a certificate to reward.
5)Investigator meeting will be annually held to conclude the progress, solve existing problems and strengthen program training.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At discharge, an average of 10 days
Time frame: 30 days
Time frame: At discharge, an average of 10 days
Time frame: 6 months
Time frame: 1 year
Henan Institute of Cardiovascular Epidemiology
Other
Henan ST-segment Elevation Myocardial Infarction (STEMI) Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02445885
Cardiovascular Diseases, Heart Diseases
Copenhagen, Capital Region, Denmark
View Trial DetailsNCT05895123
Cardiovascular Diseases, Heart Diseases
Damanhūr, Egypt
View Trial DetailsNCT03671603
Arterial Occlusive Diseases, Arteriosclerosis
Kaifeng, Contact:, China
View Trial DetailsNCT02164695
Cardiovascular Diseases, Heart Diseases
Wŏnju, Gangwon-do, South Korea
View Trial Details